by Carolyn Hendler, JD
“Despite the recommendation by the U.S. Centers for Disease Control and Prevention (CDC) that young children between the ages of six months and four years get vaccinated for COVID-19, only four to five percent of children in this age group have received the controversial mRNA COVID vaccines distributed by Pfizer/BioNTech and Moderna for administration to young children under an Emergency Use Authorization (EUA).”
“The problem in issuing the existing smallpox/monkeypox vaccine an EUA, is that it was already approved by the FDA, even though it has not been tested in the public much beyond the initial trials conducted by the drug company.